Life sciences work—across transactions, intellectual property and regulatory matters—provided a bright spot in Big Law business in 2020 that firms expect to fuel an even more promising 2021.

The pandemic, in particular, has created an increasing need for regulatory and corporate experts, among others, as companies look to the digital world to innovate and solve unmet needs in health care.

In response to the revelatory moment, law firms themselves are harnessing expertise in the sector and innovating across practice areas. Life sciences and health care Big Law leaders believe that capitalizing on pandemic-driven demand means fostering cross-disciplinary and forward-thinking teams that will ultimately advance their competitive edge in the heavily scrutinized and capital-intensive world of life sciences.